ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,659.69
0.26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Forte Biosciences Inc (FBRX)

  7. Forte Biosciences Inc (FBRX) News

Forte Biosciences (FBRX)

Forte Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FBRX
DateTimeSourceHeadlineSymbolCompany
13/05/202421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBRXForte Biosciences Inc
13/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
16/02/202421:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FBRXForte Biosciences Inc
14/02/202421:54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FBRXForte Biosciences Inc
05/01/202422:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FBRXForte Biosciences Inc
03/01/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
03/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/12/202315:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
15/12/202323:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
13/12/202300:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
09/12/202300:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
08/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
22/11/202322:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
13/11/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBRXForte Biosciences Inc
03/10/202321:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
03/10/202321:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
26/09/202321:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FBRXForte Biosciences Inc
20/09/202322:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202322:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202322:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202322:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202322:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
20/09/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
14/09/202321:00Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
14/09/202315:50Business WireISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual MeetingNASDAQ:FBRXForte Biosciences Inc
11/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBRXForte Biosciences Inc
08/09/202321:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FBRXForte Biosciences Inc
06/09/202321:31Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
06/09/202320:15Business WireConcerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s BoardroomNASDAQ:FBRXForte Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:FBRX

Your Recent History

LSE
BIRD
Blackbird
LSE
ITV
Itv
LSE
GKP
Gulf Keystone Petroleum
LSE
NG.
National Grid
LSE
POS
Plexus
LSE
GOLD
LSE
SCLP
Scancell
LSE
KRS
Keras Resources
LSE
TERN
Tern
LSE
CNR
Condor Gold
LSE
SAR
Sareum
LSE
AAZ
Anglo Asian Mining
LSE
LLOY
Lloyds Banking
LSE
BLOE
Block Energy
LSE
INSG
Insig Ai
LSE
SYME
Supply@me Capital
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved